GeneSeek Chooses Sequenom's System for Multi-Species DNA Testing
News Dec 20, 2005
Sequenom, Inc. and GeneSeek, Inc. have announced that GeneSeek has agreed to purchase Sequenom's proprietary MassARRAY® genetic analysis system for animal diagnostic testing, traceability and contract research and development.
GeneSeek intends to use Sequenom's high throughput MassARRAY system which is designed to offer flexible panel design, accuracy and call rate efficiency to conduct animal genotyping for a number of its customers.
For example, GeneSeek will use the MassARRAY system to perform high-throughput single nucleotide polymorphism genotyping of cattle in support of their recently announced collaboration with Merial Limited.
"We are pleased that GeneSeek selected Sequenom's MassARRAY system with the iPLEX™ assay," stated Harry Stylli, MBA, Ph.D., President and Chief Executive Officer of Sequenom, Inc.
"There is growing demand for our platform in the high growth potential animal genotyping market."
"Our genotyping services are relevant to gene discovery, diagnostic testing and identity management across many species, with important applications for agribusiness, food safety and pharmaceutical research," stated Abraham Oommen, Chief Executive Officer of GeneSeek, Inc.
"The iPLEX assay's flexibility supported our choice of Sequenom's MassARRAY system for providing SNP genotyping services to our global customer base."
Bird and Turtle Chromosomes Help Identify Dinosaur DNANews
Researchers have used bird and turtle DNA to extrapolate the chromosome structure of their common ancestor that lived around 260 million years ago – 20 million years before the dinosaurs first emerged. They were then able to trace the evolution of avian and non-avian dinosaur DNA through to the present day.
Over 130 Glaucoma Gene Variants Could Help Predict BlindnessNews
An international study has identified 133 genetic variants that could help predict the risk of developing glaucoma, the world’s leading cause of incurable blindness. The findings are an advance in the fight to tackle the incurable, degenerative condition, which has virtually no symptoms in the early stages, and could lead to a genetic-based screening program.READ MORE
Yeast Study Performs Hundreds of Simultaneous CRISPR EditsNews
A new technique which can alter hundreds of different genes at once in baker's yeast could greatly speed up CRISPR-Cas9 editing and offer a way to perform high-throughput functional genomics.READ MORE